Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers.
This communication demonstrates the possibility to nucleate and grow different crystalline polymorphic forms of gabapentin (GBP) using, as nucleation templates, Langmuir monolayers of an amphiphilic calixarene at different packing densities.